Sees Q2 revenue $1.48B-$1.56B, consensus $1.46B.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW:
- Edwards Lifesciences price target raised to $95 from $85 at Mizuho
- Edwards Lifesciences price target raised to $87 from $75 at Stifel
- Edwards Lifesciences price target raised to $93 from $86 at Truist
- Edwards Lifesciences price target raised to $97 from $92 at Citi
- Citi opens two positive, one negative catalyst watches in medical technology